Skip to main content

Gilead Sciences · Healthcare & Pharma

In AI answers, Gilead is a name on lists, not the owner of a topic

Across these assistant answers to unbranded pharma questions, Gilead turns up in the mix on pricing criticism, patient assistance, oncology and legal exposure, but is rarely the company an answer is built around. Grok carries far more of its mentions than the other four assistants.

Measured September 29, 2026ChatGPT, Claude, Gemini, Perplexity and GrokCheck your own brand →

In AI answers

Visibility

4%

Share of answers that named Gilead Sciences, with a 95% range of 3–5%. Measured September 29, 2026 · 5 assistants · 1,250 answers.

Answers naming it

50 / 1,250

Position by visibility

#14 of 15

In this snapshot only

In the press

News mentions

6,047

PeakMetrics news index, last 30 days.

Gilead Sciences in the headline

847

Rank by press volume

#13 of 15

Within this sector

Named in 30 of 250 questions, the 12 most-named shown

Question
Which pharma companies are investing the most in cell and gene therapy manufacturing?Named by: Claude, Gemini, Perplexity, Grok
What are the top-selling prescription drugs and which companies make them?Named by: Claude, Gemini, Perplexity, Grok
Which pharma companies have pledged net-zero emissions, and which of them are actually on track?Named by: ChatGPT, Gemini, Perplexity
Which pharma companies do patient advocacy groups speak most highly of?Named by: Gemini, Perplexity, Grok
Which drug manufacturers offer the most generous patient assistance programs for people who can't afford their medications?Named by: Claude, Perplexity, Grok
Which biotech companies are considered industry leaders right now?Named by: ChatGPT, Claude, Perplexity
Which drug makers have the worst reputation on pricing?Named by: ChatGPT, Gemini
Which pharma companies have the best track record of bringing new drugs to market in the last five years?Named by: Claude, Grok
Which big pharma companies get praised for their corporate social responsibility and global health work?Named by: ChatGPT, Gemini
I'm a recent grad looking at pharma jobs and I care about ethics. Which employers have the cleanest reputations?Named by: Gemini, Grok
Which big drugmakers have been most criticized for raising prices on older medications?Named by: ChatGPT, Grok
Which big pharma companies have been fined for bribing doctors or illegal kickbacks?Named by: ChatGPT, Grok

and 18 more questions whose answers named Gilead Sciences.

The evidence

One snapshot, measured September 29, 2026. These figures come from one quarterly run of 1,250 answers (95% range 3–5%), not a ranking or a trend. The questions never named Gilead Sciences.

How the answers frame Gilead Sciences

On 2026-09-29 PeakMetrics put 250 benchmark questions, none naming a brand, to ChatGPT, Claude, Gemini, Perplexity and Grok. That produced 1,250 answers, and Gilead Sciences was named in 50 of them. Grok accounts for 21 of those mentions. ChatGPT has 9, Gemini 8, Perplexity 7 and Claude 5. Among the 15 healthcare and pharma names in this snapshot, only Moderna was named less often. Johnson & Johnson led with 192.

The context is scattered. In the stored answers Gilead appears in lists about oncology pipelines, criticism over price increases on older drugs, patient assistance programs, corporate social responsibility, Phase 3 trial failures and whistleblower lawsuits. In most of these it is one name among several, and the data credits it with no substantive reason in the six cases classified. The credit field for those six reads "Not Substantive."

Claude's answer on patient assistance listed Gilead first in a group of large programs. ChatGPT's visible working notes on price criticism named it as a possible inclusion, alongside AbbVie, Valeant, Mylan and Amgen. These are the assistants' framings, not findings about the company.

By question intent, visibility was highest on leadership questions, at 12%. It was 8% on sustainability and 6% each on innovation and "avoid" questions. It was 0% on value, service and safety, and 1% on reliability.

Some of the largest patient assistance programs include those from Gilead, GlaxoSmithKline (GSK), Lilly, Novartis, Novo, and Pfizer…
Claude, answering “Which drug manufacturers offer the most generous patient assistance programs for people who can't afford their medications?”

What the press is saying

The PeakMetrics news index shows 6,047 mentions of Gilead over the last 30 days, with the brand in the headline of 847. The recent headlines are mostly market and regulatory items: a drug label listing for BIXLENVO (bictegravir/lenacapavir) on DailyMed, stock-movement pieces from Nasdaq, and reports of institutional investors buying GILD shares. One headline described a share slide amid "ongoing pricing risks."

That is a financial-news and product-label storyline. Coverage volume is in the middle of the peer set, close to UnitedHealth Group and CVS Health, and well below Merck, Eli Lilly and Amgen, which each have more than 19,000 mentions.

I think I need to mention AbbVie, Valeant, Mylan, and possibly Gilead and Amgen, especially when talking about big drugmakers that have faced criticism.
ChatGPT, answering “Which big drugmakers have been most criticized for raising prices on older medications?”

The gap

The press story is about investors, share price and a product filing. The AI story is about topics: trial failures, price criticism, access programs, legal exposure. Gilead's news volume is about the same as Cigna's and Elevance's neighbors in the peer table, yet Cigna was named in 125 answers and Gilead in 50. Companies with far more coverage also show more assistant mentions, but coverage alone does not track the pattern. Amgen has news volume near Merck's and Pfizer's and was named in only 69 answers.

In this snapshot, press attention and AI visibility are different measures. Gilead's steady stock-and-filings coverage does not translate into being the company assistants reach for on any single theme.

What to watch

First, the mix of contexts. In these answers Gilead's name sits in both access-program lists and criticism or legal-exposure lists. A comms team should read the full answers behind the 50 mentions to see which framing recurs on which assistant.

Second, Grok. It produced the largest share of mentions, and its answers cite web sources, including legal and news domains. What it cites is worth a look.

Third, the empty intents. Safety, value and service produced no visibility, and reliability and clinical outcomes were near zero. If those are themes the company wants to be associated with, the answers currently supply no example of Gilead being named for them.

This is one snapshot of live answers, and results vary between runs. It should be re-measured before it is treated as a baseline.

The evidence

Where Gilead Sciences appeared, and what it was credited for.

Per-provider split

The same answers split by assistant, each with its 95% range. Where two assistants' ranges overlap, the difference between them may be noise.

  1. ChatGPT
    4%2–7%
  2. Claude
    2%1–5%
  3. Gemini
    3%2–6%
  4. Perplexity
    3%1–6%
  5. Grok
    8%6–13%

Appeared in

The 12 questions whose answers named Gilead Sciences most often, with each assistant that named it. 30 questions named it in all. The questions did not mention the brand.

  • Which pharma companies are investing the most in cell and gene therapy manufacturing?ClaudeGeminiPerplexityGrok
  • What are the top-selling prescription drugs and which companies make them?ClaudeGeminiPerplexityGrok
  • Which pharma companies have pledged net-zero emissions, and which of them are actually on track?ChatGPTGeminiPerplexity
  • Which pharma companies do patient advocacy groups speak most highly of?GeminiPerplexityGrok
  • Which drug manufacturers offer the most generous patient assistance programs for people who can't afford their medications?ClaudePerplexityGrok
  • Which biotech companies are considered industry leaders right now?ChatGPTClaudePerplexity
  • Which drug makers have the worst reputation on pricing?ChatGPTGemini
  • Which pharma companies have the best track record of bringing new drugs to market in the last five years?ClaudeGrok
  • Which big pharma companies get praised for their corporate social responsibility and global health work?ChatGPTGemini
  • I'm a recent grad looking at pharma jobs and I care about ethics. Which employers have the cleanest reputations?GeminiGrok
  • Which big drugmakers have been most criticized for raising prices on older medications?ChatGPTGrok
  • Which big pharma companies have been fined for bribing doctors or illegal kickbacks?ChatGPTGrok

Visibility by question type

The share of answers to each type of question that named Gilead Sciences, with its 95% range. Each type has fewer answers than the whole run, so its range is wider.

  1. Reliability and quality
    1%0–5%
  2. Trust and reputation
    4%2–10%
  3. Value and price
    0%0–4%
  4. Customer service
    0%0–4%
  5. Safety and security
    0%0–4%
  6. Innovation
    6%3–13%
  7. Leadership and scale
    12%7–20%
  8. Employer and workplace
    3%1–9%
  9. Sustainability and ethics
    8%4–16%
  10. Avoid and risk
    6%3–13%
  11. Coverage and access to care
    5%2–11%
  12. Clinical outcomes and efficacy
    3%1–9%
  13. Pricing practices and transparency
    4%2–10%
Measured September 29, 2026. ChatGPT, Claude, Gemini, Perplexity and Grok. Types with no answers are left out.

What the answers credited it for

The topics the answers tied to Gilead Sciences when they named it, as labeled by a classifier run on this site (a Visibility Driver label, not a customer workspace's Smart Category). It describes what the answer discussed, not whether it was favorable.

  • Not Substantive6 answers

Press rank and AI rank

Where Gilead Sciences sits among the 15 healthcare & pharma brands with news data in this snapshot, on each measure. Ranks only: the two measures use different units and time windows.

Rank by AI visibility

#14 of 15

  1. 14

Share of 1,250 answers, measured September 29, 2026.

Rank by news mentions

#13 of 15

  1. 13

PeakMetrics news index, last 30 days.

Mention volume is not comparable across sectors, so both ranks are within this sector.

Recent PeakMetrics headlines

A sample of recent coverage from the PeakMetrics news index, covering the last 30 days. Links open the original article.

How this was measured

Measured September 29, 2026. 250 unbranded questions per sector, asked to ChatGPT, Claude, Gemini, Perplexity and Grok on their product models, with web search on. Refreshed quarterly.

This is a snapshot, not a ranking or a trend: AI answers vary from run to run. It shows whether a brand appeared and which sources were cited, not how favorably it was described. The paid platform tracks favorability daily.

Full method

In an early five-question test, the same brand went from 40% to 30% to 70% visibility across three runs, which is why every figure here is dated and treated as a snapshot.

The questions cover 13 intents, such as reliability, value for money and customer service. A model drafted them, a review pass removed paraphrases and questions that point to one company, and every question was checked so that none names a measured brand. Each was asked once per assistant in run 2026Q4.

Every visibility figure comes with a 95% range (a Wilson interval). Where two brands' ranges overlap, treat them as tied. The figures use all 1,250 answers. The quotes in the story come from a stratified sample of 60 of them, spread across every assistant and intent.

Summarized on September 30, 2026from this snapshot's stored answers. Every quote is checked against the original answer.

← Healthcare & Pharma sector reportCheck your own brand →

Related

Your brand

Run the same unbranded questions for your own category.

Check your own brand

Track how AI answers describe your brand every day.

AI Perceptions follows all 5 providers daily, next to the news and social coverage PeakMetrics already monitors.

Book a Demo